Pei-Hua Lin

Title: Pei-Hua Lin: Innovator in Antibody Development

Introduction

Pei-Hua Lin is a prominent inventor based in Fremont, CA, known for his significant contributions to the field of biotechnology. He holds a total of six patents, primarily focused on the development of anti-PD-1 and anti-PD-L1 antibodies. His work has implications for cancer treatment and immunotherapy.

Latest Patents

Among his latest patents, Pei-Hua Lin has developed anti-PD-1 antibodies, which include isolated nucleic acid molecules that encode these antibodies and their antigen binding fragments. He has also provided methods for making these antibodies and related pharmaceutical compositions aimed at treating subjects. Additionally, his work on anti-PD-L1 antibodies encompasses variants, mutants, and methods for their production, further contributing to the advancement of therapeutic options in oncology.

Career Highlights

Pei-Hua Lin has worked with notable companies in the biotechnology sector, including Shanghai Henlius Biotech Inc. and Henlix Biotech Co., Ltd. His experience in these organizations has allowed him to collaborate on innovative projects that push the boundaries of current medical treatments.

Collaborations

Pei-Hua Lin has collaborated with esteemed colleagues such as Weidong Jiang and Chi-Ling Tseng, who is a woman. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.

Conclusion

Pei-Hua Lin's contributions to the field of antibody development are noteworthy and have the potential to impact cancer treatment significantly. His innovative work continues to pave the way for advancements in immunotherapy.